Onogi Futoshi, Saitoh Shu-ichi, Aikawa Kazuhiko, Ishibashi Toshiyuki, Maruyama Yukio
First Department of Internal Medicine, Fukushima Medical University, Fukushima, Japan.
Coron Artery Dis. 2007 Mar;18(2):133-40. doi: 10.1097/MCA.0b013e328010a48b.
Recently, many antioxidants have been tested in cardiovascular disease. The effect of antioxidants on alleviation of coronary vasospasm, however, remains unclear. We investigated whether chronic administration of ascorbic acid and glutathione prevents coronary vasospasm in pigs.
Balloon-induced endothelial injury in the left anterior descending coronary artery was performed every 2 weeks until 6 weeks (0, 2, 4, 6 weeks). Ten micrograms per kilogram serotonin-induced vasoconstriction was assessed before each endothelial injury and at eighth week by coronary angiography.
In endothelial injury without antioxidant group (ED group, n=12), serotonin-induced left anterior descending coronary artery vasoconstriction was augmented from 7+/-4% (0 week) to 88+/-8% (8th week, P<0.01) with electrocardiogram-ST elevation, and an increase of cyclooxygenase-2 expression and a decrease of endothelial nitric oxide synthase expression was observed at the spasm portion removed from the endothelial denuded site. In the endothelial injury group with oral administration of ascorbic acid 3 g/day and glutathione 1 g/day after the first endothelial injury (ASC+GSH group, n=12), serotonin-induced vasoconstriction was suppressed (8th week, 60+/-6%, P<0.01 vs. ED group) and endothelial nitric oxide synthase expression was fairly well maintained. Intimal thickening was observed at the left anterior descending artery spasm portion in the endothelial injury without antioxidant group but not at the corresponding portion in the ASC+GSH group.
Antioxidant therapy was partially effective to prevent coronary vasospasm, whereas intimal thickening after endothelial injury was nearly restored. From these results, chronic antioxidant therapy may well be a useful supportive therapy for the treatment of coronary vasospasm, although it has limited availability despite amelioration of endothelial dysfunction.
近年来,许多抗氧化剂已在心血管疾病中进行了测试。然而,抗氧化剂对缓解冠状动脉痉挛的作用仍不明确。我们研究了长期给予抗坏血酸和谷胱甘肽是否能预防猪的冠状动脉痉挛。
每隔2周对左前降支冠状动脉进行球囊诱导的内皮损伤,直至6周(0、2、4、6周)。在每次内皮损伤前及第8周通过冠状动脉造影评估每千克10微克血清素诱导的血管收缩。
在无抗氧化剂的内皮损伤组(ED组,n = 12)中,血清素诱导的左前降支冠状动脉血管收缩从7±4%(0周)增加到88±8%(第8周,P < 0.01),伴有心电图ST段抬高,并且在从内皮剥脱部位切除的痉挛部位观察到环氧合酶-2表达增加和内皮型一氧化氮合酶表达减少。在首次内皮损伤后口服3 g/天抗坏血酸和1 g/天谷胱甘肽的内皮损伤组(ASC + GSH组,n = 12)中,血清素诱导的血管收缩受到抑制(第8周,60±6%,与ED组相比P < 0.01),并且内皮型一氧化氮合酶表达得到较好维持。在无抗氧化剂的内皮损伤组中,左前降支动脉痉挛部位观察到内膜增厚,而在ASC + GSH组的相应部位未观察到。
抗氧化治疗对预防冠状动脉痉挛有部分效果,而内皮损伤后的内膜增厚几乎得到恢复。从这些结果来看,尽管慢性抗氧化治疗改善内皮功能障碍的作用有限,但它很可能是治疗冠状动脉痉挛的一种有用的支持性疗法。